About: Inhibition of tumor growth with antiangiogenic cancer vaccine using epitope peptides derived from human vascular endothelial growth factor receptor 1

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Inhibition of tumor growth with antiangiogenic cancer vaccine using epitope peptides derived from human vascular endothelial growth factor receptor 1 Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 October 2006

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) article scientifique publié en 2006 (fr) наукова стаття, опублікована в жовтні 2006 (uk) artículu científicu espublizáu n'ochobre de 2006 (ast) scientific article published on 01 October 2006 (en)
publication date	wds:Q79188369-107C69BB-8AF4-452B-BE1F-1ADCC7FB0930
publication date	2006-10-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q79188369-3455EA49-096A-41BA-AFB2-F2D2405161C3
language of work or name	English
author name string	wds:Q79188369-932DD8FD-DA8B-44B2-804B-FBAD05279B5E wds:Q79188369-C7CE3CD2-5B3E-432B-B689-8C60DEFBF542 wds:Q79188369-DCCF5066-7431-4787-B5A9-A7A5A8D137A3 wds:Q79188369-E7B897A7-7A9F-4213-9456-B66D195B1342 wds:Q79188369-E835FDB0-406F-41F3-9E61-350225B5C957 wds:Q79188369-F467C43B-D3D7-4594-A991-F2963F790AC3
author name string	Masabumi Shibuya Mai Yamauchi Satoshi Wada Hideaki Tahara Takuya Tsunoda Hidenobu Ishizaki
rdfs:label	Inhibition of tumor growth with antiangiogenic cancer vaccine using epitope peptides derived from human vascular endothelial growth factor receptor 1 (en) Inhibition of tumor growth with antiangiogenic cancer vaccine using epitope peptides derived from human vascular endothelial growth factor receptor 1 (nl)
skos:prefLabel	Inhibition of tumor growth with antiangiogenic cancer vaccine using epitope peptides derived from human vascular endothelial growth factor receptor 1 (en) Inhibition of tumor growth with antiangiogenic cancer vaccine using epitope peptides derived from human vascular endothelial growth factor receptor 1 (nl)
name	Inhibition of tumor growth with antiangiogenic cancer vaccine using epitope peptides derived from human vascular endothelial growth factor receptor 1 (en) Inhibition of tumor growth with antiangiogenic cancer vaccine using epitope peptides derived from human vascular endothelial growth factor receptor 1 (nl)
title	wds:Q79188369-9CAE437A-4E77-401D-B9D7-0E8943E24FAA
title	Inhibition of tumor growth with antiangiogenic cancer vaccine using epitope peptides derived from human vascular endothelial growth factor receptor 1 (en)
page(s)	wds:Q79188369-8A96DB8D-904A-4601-8A38-D34F7D26EC7F
page(s)	5841-5849
instance of	wds:Q79188369-109BCE81-7937-4590-A9F4-28F1FCD7530A
instance of	scholarly article
main subject	wds:Q79188369-4071FE03-F8F4-4C79-8824-8396F9A3EDD5
main subject	angiogenesis inhibitor
PubMed ID	wds:Q79188369-520FD528-BF9F-411C-8277-AD6E9AF04214
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/17020992
PubMed ID	17020992
published in	wds:Q79188369-2736BB1C-7A1F-49A9-AC34-CF431CD4627D
published in	Clinical Cancer Research
issue	wds:Q79188369-1059E6F5-E718-422E-AF02-F80D4666CBEB
volume	wds:Q79188369-767483D6-6D93-4F10-9788-27DE3774787A
issue	19
volume	12
DOI	wds:Q79188369-EBFF09F9-5BA1-4A6F-BECB-79F9EEE9477F
DOI	http://dx.doi.org/10.1158/1078-0432.CCR-06-0750
DOI	10.1158/1078-0432.CCR-06-0750
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q79188369
is cites work of	Peptide-Based Treatment: A Promising Cancer Therapy Cancer anti-angiogenesis vaccines: Is the tumor vasculature antigenically unique? A phase I study of combination vaccine treatment of five therapeutic epitope-peptides for metastatic colorectal cancer; safety, immunological response, and clinical outcome Multiple therapeutic peptide vaccines consisting of combined novel cancer testis antigens and anti-angiogenic peptides for patients with non-small cell lung cancer Trial Watch: Peptide vaccines in cancer therapy Phase I trial of OTS11101, an anti-angiogenic vaccine targeting vascular endothelial growth factor receptor 1 in solid tumor. Clinical phase I study of elpamotide, a peptide vaccine for vascular endothelial growth factor receptor 2, in patients with advanced solid tumors. The coordinated p53 and estrogen receptor cis-regulation at an FLT1 promoter SNP is specific to genotoxic stress and estrogenic compound Predictive biomarkers for the efficacy of peptide vaccine treatment: based on the results of a phase II study on advanced pancreatic cancer. A phase ΙI study of five peptides combination with oxaliplatin-based chemotherapy as a first-line therapy for advanced colorectal cancer (FXV study). RACK1 regulates VEGF/Flt1-mediated cell migration via activation of a PI3K/Akt pathway Identification of HLA-A24-restricted novel T Cell epitope peptides derived from P-cadherin and kinesin family member 20A Phase I clinical trial of peptide vaccination with URLC10 and VEGFR1 epitope peptides in patients with advanced gastric cancer Exosomes as a tumor immune escape mechanism: possible therapeutic implications Vaccines targeting tumor blood vessel antigens promote CD8(+) T cell-dependent tumor eradication or dormancy in HLA-A2 transgenic mice CD8+ T-cell responses against hemoglobin-beta prevent solid tumor growth. Intratumoral IL-12 gene therapy results in the crosspriming of Tc1 cells reactive against tumor-associated stromal antigens Therapeutic cancer vaccines in combination with conventional therapy MicroRNA-6826 and -6875 in plasma are valuable non‑invasive biomarkers that predict the efficacy of vaccine treatment against metastatic colorectal cancer miR-196b, miR-378a and miR-486 are predictive biomarkers for the efficacy of vaccine treatment in colorectal cancer miR-125b-1 and miR-378a are predictive biomarkers for the efficacy of vaccine treatment against colorectal cancer Phase I clinical study of multiple epitope peptide vaccine combined with chemoradiation therapy in esophageal cancer patients Gastrointestinal bleeding during anti-angiogenic peptide vaccination in combination with gemcitabine for advanced pancreatic cancer Phase II clinical trial of peptide cocktail therapy for patients with advanced pancreatic cancer: VENUS-PC study. A pilot study of peptide vaccines for VEGF receptor 1 and 2 in patients with recurrent/progressive high grade glioma. A Pilot Study of Vaccine Therapy with Multiple Glioma Oncoantigen/Glioma Angiogenesis-Associated Antigen Peptides for Patients with Recurrent/Progressive High-Grade Glioma A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2 Use of immunotherapy in the treatment of gastric cancer Clinical and histopathological analyses of VEGF receptors peptide vaccine in patients with primary glioblastoma - a case series Limitations of Anti-Angiogenic Treatment of Tumors Targeting Angiogenesis With Peptide Vaccines
is cites work of	wds:Q26777032-42A22FCD-1603-4160-A191-D4EEAA3EF876 wds:Q26778150-D4ADAB3A-E590-419E-B0FF-31CA41C11D50 wds:Q33556780-7CE1AA1F-7E03-410F-8466-72CFE685CD55 wds:Q37771267-6679FD9E-08E2-49B0-A95B-1C1A198E8EB7 wds:Q37707611-800BCA62-0D9B-45AB-891A-5B7CEE323257 wds:Q39317151-85F8AA9C-A541-4AE1-A176-10F442EE3322 wds:Q54480921-F13AB96D-D9AD-4B36-A734-1477F389EB62 wds:Q46803210-3312EC92-A027-4C53-8350-AF5A0479BCF4 wds:Q92058710-8A2AA6D2-7B2E-46F9-B694-572E13ECA0C1 wds:Q34757171-ED29767A-BB6A-425F-A065-FE712DD6AFCF wds:Q36803441-065F2AEC-9B29-4017-ADB9-8B0B74974394 wds:Q42734544-9F3F7293-1195-4C46-81B5-291AA3C4C803 wds:Q54485562-5A57816A-D51F-45E0-8C7F-D2A5520CB05A wds:Q85624241-783BD0EC-F33D-4BDB-A378-30D77059D193 wds:Q21245472-ACCF131A-A229-4A41-AA11-B6019D1163E2 wds:Q28473733-DA4DD3E1-6EAA-4972-83F1-BA901681C1A7 wds:Q41143092-818232D1-C112-4F8B-AC7B-EBCC08A3A0A8 wds:Q55001435-05E2CD03-F9AE-4C2A-B74F-D3AE57BDEC1E wds:Q37003256-F2972854-6F5A-4D80-8304-89E0963E0793 wds:Q39611324-259A6C8A-8BB4-4727-A530-39E5FB20D0E9

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software